Phase 3 study of LB1148 in lead indication for postoperative return of bowel function on track to commence Q2 2022…
PGX Technology continues to demonstrate ability to generate novel bioactive delivery systems for nutraceuticals, drug delivery and wound healingEDMONTON, Alberta,…
MARKHAM, Ontario, May 13, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced…
FREMONT, CA, May 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical…
Ozop Plus is Reinsurance Symposium Premier Sponsor Florida, NY, May 13, 2022 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. Inc. (OZSC),…
Waivers remove requirement to conduct pediatric clinical studies to support cosibelimab marketing authorization applications in EuropeWALTHAM, Mass., May 13, 2022…
POINT's manufacturing facility initiated supply for the Phase 3 SPLASH trial. Randomization of patients for the SPLASH trial expanded to…
PHILADELPHIA, PA, May 13, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical…
Company looks to improve capital structure and create long-term value for all security holdersTORONTO, May 13, 2022 (GLOBE NEWSWIRE) --…
GLENDALE, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- The hemp products filled with different cannabinoids have become very popular as…